Seven Eight Capital’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Seven Eight Capital’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-5,800	Closed	-$72K	–	763
2016 Q4	$72K	Buy	+5,800	New	+$69.9K	0.01%	485
2016 Q3	–	Sell	-15,800	Closed	-$117K	–	640
2016 Q2	$117K	Buy	+15,800	New	+$119K	0.04%	381
2015 Q2	–	Sell	-2,526	Closed	-$21K	–	744
2015 Q1	$21K	Buy	2,526 +2,500	+9,615%	+$18.5K	0.04%	351
2014 Q4	$0	Sell	26 -21,751	-100%	-$136K	﹤0.01%	740
2014 Q3	$118K	Buy	21,777 +10,577	+94%	+$61.8K	0.09%	294
2014 Q2	$71K	Buy	+11,200	New	+$77K	0.07%	339

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Seven Eight Capital's ARIA Position: Q1 2017 in Review

Seven Eight Capital sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 5,800 shares — an estimated $72K sold.

Seven Eight Capital first reported a position in ARIA in Q2 2014 and held it in 6 quarters. The position peaked at $118K in Q3 2014. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Seven Eight Capital reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Seven Eight Capital sold 5,800 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $72K.
Seven Eight Capital first reported a position in Ariad Pharmaceuticals Inc in Q2 2014 and held it in 6 quarters.
Seven Eight Capital's Ariad Pharmaceuticals Inc position peaked at $118K in Q3 2014.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Seven Eight Capital's 13F filing for Q1 2017, filed 15 May 2017.